Found 14 matching trials
Study of Incidence of Respiratory Tract AEs in Patients Treated With Tyvaso® Compared to Other FDA Approved PAH Therapies N/A A surveillance of respiratory tract related adverse events in patients trea...
Show More Location
Cardiovascular Associates, P.C.
Learn More & Join Trial
Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in Pulmonary Arterial Hypertension (PAH) Subjects PHASE4 This is a 24-month, multi-center, prospective, open-label, safety evaluatio...
Show More Location
University of Alabama Birmingham
Learn More & Join Trial
Safety and Efficacy of Inhaled Treprostinil in Adult PH With ILD Including CPFE PHASE2 This was a multicenter, randomized (1:1 inhaled treprostinil: placebo), dou...
Show More Location
University of Alabama at Birmingham
Learn More & Join Trial
A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD) PHASE3 The primary objective of this study is to demonstrate the efficacy of inhal...
Show More Location
The University of Alabama at Birmingham
Learn More & Join Trial
Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso® PHASE2 The purpose of this multi-center, open-label, safety and tolerability study...
Show More Location
The University of Alabama at Birmingham
Learn More & Join Trial
Inhaled Treprostinil for Dyspnea and Exercise Intolerance in Mild COPD PHASE2 The goal of this clinical trial is to evaluate the impact of inhaled Trepro...
Show More Status
Active Not Recruiting
Location
Clinical Physiology Laboratory
Learn More & Join Trial
Safety and Tolerability of Inhaled Treprostinil in Adult PH Due to COPD PHASE2 This is a multicenter, single-arm trial to evaluate the safety and efficacy...
Show More Location
Multiple Locations
Learn More & Join Trial
Clinical Investigation Into Inhaled Treprostinil Sodium in Patients With Severe Pulmonary Arterial Hypertension (PAH) PHASE3 This is a double-blind placebo-controlled clinical investigation into the e...
Show More Location
University of Alabama
Learn More & Join Trial
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) PHASE3 Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled...
Show More Location
UAB Lung Health Center
Learn More & Join Trial
Acute Effects of Inhaled Treprostinil in Fontan Patients PHASE2 In this pilot study investigators propose to explore the effects of a local...
Show More Location
Cincinnati Children's Hospital Medical Center
Learn More & Join Trial